BML Capital Management, LLC Diversified Active

Location: Zionsville, IN

CIK: 0001616824 · Show all filings

Period: Q3 2023 (← Previous) (Next →)

Filing Date: Oct 23, 2023

Total Value: $109M (100.0% shares, 0.0% debt)

Holdings (26)

SGOV ISHARES TR 25.0%
Value $27.18M Shares 270,000 Est. Cost $100.62 Unrealized
BIL SPDR SER TR 16.9%
Value $18.36M Shares 200,000 Est. Cost $91.64 Unrealized
AVIR ATEA PHARMACEUTICALS INC 13.2%
Value $14.4M Shares 4,800,000 Est. Cost $3.56 Unrealized -4.5%
CYTEIR THERAPEUTICS INC 8.5%
Value $9.23M Shares 3,250,008 Est. Cost $1.84 Unrealized
AVROBIO INC 5.7%
Value $6.163M Shares 4,001,627 Est. Cost $1.50 Unrealized
ADVERUM BIOTECHNOLOGIES INC 5.4%
Value $5.872M Shares 3,915,000 Est. Cost $0.58 Unrealized
TALARIS THERAPEUTICS INC 5.2%
Value $5.62M Shares 2,000,000 Est. Cost $1.92 Unrealized
CLYM ELIEM THERAPEUTICS INC 4.7%
Value $5.098M Shares 1,938,263 Est. Cost $2.92 Unrealized -6.5%
ATHIRA PHARMA INC 3.2%
Value $3.443M Shares 1,704,362 Est. Cost $2.76 Unrealized
ASTC ASTROTECH CORP 2.0%
Value $2.226M Shares 220,410 Est. Cost $11.26 Unrealized +0.1%
ORMP ORAMED PHARMACEUTICALS INC 1.9%
Value $2.039M Shares 781,292 Est. Cost $2.96 Unrealized -0.9%
ARCA BIOPHARMA INC 1.3%
Value $1.421M Shares 706,930 Est. Cost $2.37 Unrealized
PASSAGE BIO INC 1.2%
Value $1.355M Shares 2,058,767 Est. Cost $1.01 Unrealized
FORTE BIOSCIENCES INC 1.1%
Value $1.166M Shares 1,761,702 Est. Cost $1.00 Unrealized
MIST MILESTONE PHARMACEUTICALS IN 0.8%
Value $845K Shares 272,500 Est. Cost $4.74 Unrealized -34.4%
ELVN ENLIVEN THERAPEUTICS INC 0.6%
Value $683K Shares 50,000 Est. Cost $20.34 Unrealized -17.2%
RVP RETRACTABLE TECHNOLOGIES INC 0.5%
Value $595K Shares 499,959 Est. Cost $2.13 Unrealized -44.7%
VERRICA PHARMACEUTICALS INC 0.5%
Value $583K Shares 150,000 Est. Cost $2.75 Unrealized
VTGN VISTAGEN THERAPEUTICS INC 0.5%
Value $524K Shares 100,000 Est. Cost $4.44 Unrealized 0.0%
LSTA LISATA THERAPEUTICS INC 0.5%
Value $522K Shares 243,839 Est. Cost $2.53 Unrealized
QQQ INVESCO QQQ TR 0.4%
Value $444K Shares 108 Est. Cost Unrealized
NEXTCURE INC 0.4%
Value $395K Shares 306,465 Est. Cost $1.48 Unrealized
NEOLEUKIN THERAPEUTICS INC 0.4%
Value $390K Shares 98,664 Est. Cost $3.95 Unrealized
CALC CALCIMEDICA INC 0.2%
Value $236K Shares 88,781 Est. Cost $4.37 Unrealized -24.4%
RAIN ONCOLOGY INC 0.1%
Value $62,848 Shares 72,926 Est. Cost $1.20 Unrealized
SURROZEN INC 0.0%
Value $43,743 Shares 89,271 Est. Cost $0.60 Unrealized